Edition:
United States

Abiomed Inc (ABMD.O)

ABMD.O on Nasdaq

116.92USD
9 Dec 2016
Change (% chg)

$-1.16 (-0.98%)
Prev Close
$118.08
Open
$118.76
Day's High
$118.76
Day's Low
$116.42
Volume
322,991
Avg. Vol
495,514
52-wk High
$132.95
52-wk Low
$67.81

Select another date:

Thu, Oct 27 2016

BRIEF-Abiomed Q2 revenue of $103 million, up 35 pct over prior year

* Abiomed announces q2 fy 2017 revenue of $103 million, up 35% over prior year

BRIEF-Abiomed receives FDA ide approval for initiation of door to unloading prospective feasibility study

* Abiomed receives fda ide approval for initiation of door to unloading (dtu) prospective feasibility study

BRIEF-Abiomed receives FDA IDE approval for initiation of DTU prospective feasibility study

* Receives FDA IDE approval for initiation of door to unloading (DTU) prospective feasibility study

BRIEF-Abiomed reports Q2 FY 2017 gaap earnings per share $0.20

* Announces Q2 FY 2017 revenue of $103 million, up 35% over prior year

BRIEF-Abiomed Impella 2.5 and Impella 5.0 heart pumps receive regulatory approval from Japan Ministry of Health, Labor & Welfare

* Abiomed Impella 2.5 and Impella 5.0 heart pumps receive regulatory approval from Japan Ministry of Health, Labor & Welfare

BRIEF-Abiomed reports Q1 gaap earnings per share of $0.29

* Is maintaining its fiscal year guidance for gaap operating margin in range of 18% to 20%

Select another date: